Cephalon’s Fentora Approved For Breakthrough Cancer Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr is free to launch generic of Actiq, Fentora’s predecessor.
You may also be interested in...
Cephalon’s Fentora sNDA Gets FDA Advisory Panel Review
Company tells “The Pink Sheet” DAILY advisory committee meeting slated for May 6 is routine for schedule II opioids.
Cephalon’s Fentora sNDA Gets FDA Advisory Panel Review
Company tells “The Pink Sheet” DAILY advisory committee meeting slated for May 6 is routine for schedule II opioids.
Cephalon Submits Fentora sNDA For Chronic Pain
Application includes strengthened risk management plan to ensure appropriate patient use and dosing, a critical concern after deaths were reported following unapproved uses.